Concepedia

Lynn M. Abell

LM

25

Publications

1.1K

Citations

20

H-Index

1988

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Durham University

Bristol-Myers Squibb (Germany)

DuPont (United States)

University of Wisconsin–Madison

Lynn M. Abell is an author at Bristol-Myers Squibb (United States) specializing in medicine, engineering, and natural sciences.

Top concepts

Publications per year

1988–2020

25

Publications

25

Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form

Micah T. Nelp, Patrick A. Kates, John T. Hunt et al. · Proceedings of the National Academy of Sciences · 2018 · 203 citations · Full text

Oxygenase side reactions of acetolactate synthase and other carbanion-forming enzymes

Lynn M. Abell, John V. Schloss · Biochemistry · 1991 · 88 citations

, , +18

Conformationally Constrained <i>ortho-</i>Anilino Diaryl Ureas: Discovery of 1-(2-(1′-Neopentylspiro[indoline-3,4′-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a Potent, Selective, and Bioavailable P2Y<sub>1</sub> Antagonist

Jennifer X. Qiao, Tammy C. Wang, Réjean Ruel et al. · Journal of Medicinal Chemistry · 2013 · 69 citations · Full text

, , +13

A new acid-processing route to polyaniline films which exhibit metallic conductivity and electrical transport strongly dependent upon intrachain molecular dynamics

P.N. Adams, P. Devasagayam, S.J. Pomfret et al. · Journal of Physics Condensed Matter · 1998 · 65 citations

, , +17

Discovery of 2-(Phenoxypyridine)-3-phenylureas as Small Molecule P2Y<sub>1</sub> Antagonists

Hannguang J. Chao, Huji Turdi, Timothy F. Herpin et al. · Journal of Medicinal Chemistry · 2013 · 58 citations · Full text

, , +20

Rows per page

1–5 of 25